Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee

Former CEO of the Clinical Products Division at Siemens Healthcare joins the firm on 1 April

Clariant, a leading speciality chemicals company, has appointed Britta Fuenfstueck as a new member of its Executive Committee.

Fuenfstueck, former CEO of the Clinical Products Division at Siemens Healthcare, will join the firm on 1 April.

Fuenfstueck has been CEO of the Clinical Products Division at Siemens Healthcare since 2013. During her career with the firm, she held various leadership positions, including CEO of the Molecular Imaging Business Unit, Vice President, Strategy and M&A for the Healthcare Sector, as well as Director, Product Portfolio and Planning, Marketing and Sales, for Siemens’ Magnetic Resonance Business Unit. She studied engineering physics at the Johannes Kepler University in Linz, Austria and began her career with the Boston Consulting Group in 1998.

As of 1 April, Clariant's Executive Committee will comprise CEO Hariolf Kottmann, CFO Patrick Jany, Fuenfstueck, and Christian Kohlpaintner.

Companies